Topic: United States

U.S. approves Monsanto drought-tolerant GM corn

WASHINGTON (Reuters) - Monsanto's genetically engineered, drought resistant corn is deregulated, the U.S. Agriculture Department said Thursday, clearing the variety for sale.USDA approved the variety after reviewing environmental and risk assessments, public comments and research data from Monsanto.Corn is the most widely ...

Merck CEO defends hefty research spending

NEW YORK (Reuters) - The chief executive of Merck & Co on Tuesday defended his refusal to slash the drugmaker's $8 billion research budget and warned that global price constraints threaten the pharmaceutical industry's ability to innovate.The drug industry is embroiled in ...

AstraZeneca slashes 1,150 U.S. sales jobs

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...

AstraZeneca to cut 1,150 U.S. sales jobs

LONDON (Reuters) - AstraZeneca is cutting nearly a quarter of its U.S. sales force in a second wave of redundancies in as many months as it seeks to reduce costs.Britain's second biggest drugmaker said on Wednesday it would cut about 1,150 sales ...

AstraZeneca to cut 1,150 sales jobs in U.S.

(Reuters) - AstraZeneca said it will cut about 1,150 U.S. sales jobs, and expects to take a related charge of about $50-$100 million in the fourth quarter.The company said the job cuts, which will account for about 24 percent of the company's ...

FDA sees huge opportunities in opening up drug data

LONDON (Reuters) - Regulators and drugmakers need to find ways to make more clinical data openly available, since vital knowledge about fighting disease is often locked away in confidential databases, the head of the U.S. drugs watchdog said on Monday.Food and Drug ...

UK lawmakers to probe medicine shortages

LONDON (Reuters) - A continuing shortage of some essential medicines in Britain is to be investigated by members of parliament, following complaints by pharmacists that vital supplies are being lost to exports.The All-Party Pharmacy Group, which announced its inquiry on Monday, said ...

Novartis unit pays $150 million to end drug-price dispute

ZURICH (Reuters) - Novartis' Sandoz unit has agreed to pay $150 million Swiss francs to settle claims it charged the U.S. and state governments inflated prices for drugs, a Swiss newspaper reported on Sunday.Under the deal Novartis will pay the U.S. government ...

Apple names Levinson chair; Disney CEO joins board

(Reuters) - Apple Inc named long-serving director Arthur Levinson chairman of its board, filling a seat vacated by co-founder Steve Jobs, who died in October after a years-long struggle with cancer.Walt Disney Co CEO Bob Iger, who had a strong relationship with ...

Novartis drug helps in severe childhood arthritis

ZURICH (Reuters) - Novartis' Ilaris helps patients with the most serious form of childhood arthritis, a second late-stage study has shown, further boosting prospects for the Swiss drugmaker's medicine that hit a setback earlier this year.Ilaris, or ACZ885, met both of its ...
Previous